purity profile raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-02-09 and is reviewed periodically as new material appears.
Interpretation depends on study phase and duration. Phase 2 programs are powered for weight and safety signals, not for cardiovascular or renal outcomes, which require event-driven designs. Gastrointestinal events such as nausea, diarrhea, vomiting, and constipation are the most frequently reported adverse effects and tend to cluster around dose escalation. Small increases in heart rate have been described. Because follow-up after treatment discontinuation is limited, questions about weight regain and durability are open rather than answered.
Trial reports for this compound rely on a small set of repeated measures. Body weight is normally expressed as percent change from baseline at a fixed week, with absolute kilograms given secondarily. Glycemic endpoints include HbA1c, fasting glucose, and, in some protocols, continuous glucose monitoring summaries. Imaging endpoints such as MRI-derived proton density fat fraction quantify liver fat. Standardization matters because a percent change and a categorical responder analysis can tell different stories about the same dataset.
Characterization panels may add amino acid analysis for compositional confirmation, circular dichroism for secondary structure in solution, and light scattering for aggregation tendency. Aggregation is a central concern for peptides bearing hydrophobic side chains, since it can lower measured potency and complicate accurate dosing. Stability studies examine temperature, humidity, pH, and light exposure over defined intervals, reporting the percentage of intact peptide remaining. Results depend strongly on the assay used, so comparing values across studies requires matching method details.
Peptide content and purity are commonly measured by reversed-phase high-performance liquid chromatography with ultraviolet detection, using gradient elution over a C18 column. Identity is confirmed by mass spectrometry, because the theoretical monoisotopic mass allows unambiguous assignment of the main component. Impurity profiling resolves deletion sequences, oxidized residues, and truncated fragments. Since the molecule carries a lipophilic side chain, mobile phases often include ion-pairing agents and organic modifiers to keep peaks symmetric.
| Property | Value | Notes |
|---|---|---|
| Trial design | Randomized, double-blind, placebo-controlled | Frequently includes dose-escalation arms |
| Weight endpoint | Percent change from baseline | Reported at a prespecified week |
| Liver fat endpoint | MRI proton density fat fraction | Non-invasive imaging measure |
| Body composition method | Dual-energy X-ray absorptiometry | Separates fat mass from lean mass |
| Common adverse events | Nausea, diarrhea, vomiting | Reported most often during dose escalation |
临床研究通常测量体重、腰围、空腹血糖、糖化血红蛋白和血脂，并记录不良事件。药代动力学评估关注浓度-时间曲线，药效动力学评估关注代谢标志物变化。体重下降由能量摄入减少、能量消耗变化和脂肪组织重塑共同造成，具体权重仍不明确。研究之间的终点定义和随访时长差异使横向比较复杂。
瑞他鲁肽同时激活GLP-1受体、GIP受体和胰高血糖素受体，这三者均属于B类G蛋白偶联受体。受体激活后主要经cAMP信号通路传递效应。GLP-1成分与食欲抑制和胃排空延缓相关，GIP成分影响脂肪组织与胰岛素分泌，胰高血糖素成分则促进肝糖输出和能量消耗。各受体贡献的相对比例在人体中尚未完全量化。
该分子是经过结构修饰的合成肽，通过脂肪酸侧链与白蛋白结合，从而延长循环时间。皮下给药后，药物逐步释放并分布至组织。降解主要依赖蛋白酶，肾脏清除占次要地位。人体半衰期以天为单位，但准确数值随检测方法和个体差异而变；组织分布与受体占有率仍是开放问题。
Quantification of the peptide in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. This approach separates the analyte from matrix components and detects it by mass-to-charge transitions specific to the molecule. Immunoassays offer higher throughput but can cross-react with related peptides and metabolites, so mass spectrometric methods are preferred when structural confirmation is required. Method validation typically addresses accuracy, precision, selectivity, and stability under handling conditions.
Several questions remain unresolved. It is not yet known whether the compound reduces cardiovascular events or mortality, because outcome studies require long follow-up. The durability of weight reduction after treatment withdrawal is uncertain, and rebound has been observed with other incretin-based therapies. Long-term safety data covering several years are limited. Effects in adolescents, in pregnancy, and in people with significant kidney or liver impairment have not been characterized in published reports.
Randomized studies of retatrutide measure change in body weight as a percentage of baseline, along with absolute weight loss. Glycemic endpoints include hemoglobin A1c and fasting plasma glucose. Investigators also track blood pressure, lipid fractions, and liver fat content to characterize effects beyond weight alone. Trial designs typically use double-blind, placebo-controlled groups with periodic dose escalation, and they record adverse events throughout both treatment and follow-up periods.
retatrutide 是一种人工合成的多肽，设计目标是同时作用于 GIP、GLP-1 与胰高血糖素三种受体。这种三重激动设计试图把多条代谢通路的调节整合进单一分子，而不是只依赖一种肠促胰素受体。分子骨架以天然肽序列为基础，经过非天然氨基酸替换和脂肪酸侧链修饰，以获得更长的作用时间。该方向属于多受体激动剂研究的一部分，与双重激动剂的工作并行推进。
三种受体在能量平衡中的分工并不相同：GLP-1 与 GIP 受体主要参与胰岛素分泌和食欲调节，胰高血糖素受体则与能量消耗及肝糖输出相关。同时激活三者可能产生叠加效应，也可能出现相互制约，具体结果取决于受体亲和力与组织分布。这种组合在理论上可能同时影响体重与血糖指标，但协同关系的细节仍处在研究阶段。
Solid material is generally held at -20 °C or colder, while reconstituted solutions are kept at 2-8 °C and used within a short window. Buffers that maintain a slightly acidic to neutral pH tend to improve short-term peptide stability. Repeated warming and cooling of stock solutions promotes aggregation and should be avoided. Container closures should remain intact, since adsorption to some plastics can reduce the amount of peptide in solution.
Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatographic profiles reveal related impurities, truncated sequences, and oxidation products, while mass measurement confirms the expected molecular mass. Purity values for research material are typically reported as a percentage by peak area. Reference standards help calibrate retention behavior across instruments. Independent laboratories emphasize method suitability because results depend heavily on column chemistry, gradient, and detection wavelength. Batch-to-batch comparison relies on the same validated method.
40 CFR Part 792, Good Laboratory Practice Standards, covers the broader application of GLP standards for nonclinical laboratory studies conducted for assessing the safety or efficacy of chemical substances, including pesticides, under various regulatory programs overseen by the EPA. This regulation applies to nonclinical laboratory studies conducted for various purposes beyond pesticides, encompassing studies related to chemicals, drugs, food additives, and other substances regulated by the EPA. This part has a broader scope and is applicable to a wider range of substances and regulatory programs. It covers a more diverse range of nonclinical studies, including those related to chemical substances other than pesticides. This could include studies conducted for assessing the safety of industrial chemicals, pharmaceuticals, food additives, and other substances subject to EPA regulation. It operates across various regulatory programs within the EPA, reflecting a broader framework for ensuring the quality and reliability of nonclinical study data used in regulatory decision-making. While both 40 CFR Part 160 and 40 CFR Part 792 address GLP standards for laboratory studies, they differ significantly in terms of scope, applicability, and the specific regulatory context in which they operate. Part 160 is tailored to pesticide registration under FIFRA, whereas Part 792 is a more comprehensive framework applicable to a wider range of laboratory studies conducted for regulatory purposes across different EPA programs.
The adrenergic receptors were discovered Henry Hallett Dale in 1906 and the α- and β-adrenergic receptors were differentiated by Raymond P. Ahlquist in 1948. In 1967, the β-adrenergic receptors were further differentiated into the β1- and β2-adrenergic receptors by Alonzo M. Lands. The first beta blocker to be developed was dichloroisoprenaline, based on structural modification of the β-adrenergic receptor agonist isoprenaline (isoproterenol). It was described by C. E. Powell and I. H. Slater in 1958. However, dichloroisoprenaline had significant partial agonism and sympathomimetic activity and hence was not a pure antagonist. James Black and John Stephenson described pronethalol (nethalide; ICI-38,174; Alderlin) as a purely antagonistic beta blocker in 1962. But pronethalol suffered from off-target activity and associated side effects and toxicity. As such, it did not enter widespread use and was soon discontinued. In 1964, Black and colleagues published on propranolol (ICI-45,520; Inderal), which did not have the problems of earlier beta blockers. It was introduced for medical use under the brand name Inderal the same year and became the first widely used beta blocker. Since the introduction of propranolol, there have been three generations of beta blockers with different pharmacological properties, with numerous beta blockers having been developed and introduced for medical use.
Presumably, these genetic abnormalities lead to the activation of the NF-κB pathway and/or other cellular activation pathways which promote the survival, proliferation, and/or other malignant phenotypic traits in pDC and thereby cause BPDCN.
=== Second year === Reportedly, from about three dozen officers on a promotion list, most of them white men, Hegseth blocked the promotion of two women and two Black officers. According to The New York Times, "It is exceedingly rare that a one-star list draws such intense scrutiny from a defense secretary." In early 2026, reports emerged of the dismissal or retirement of several senior military commanders amid rising military tensions between the United States and Iran and broader instability in the Middle East. These developments were described as part of a broader shift in Pentagon leadership, with multiple senior officers reportedly stepping down or being removed from their positions. Media outlets reported concerns regarding internal disagreements within the defense establishment and the potential impact on the stability and operational readiness of the military command structure. Some reactions criticized the rationale for the reductions, with concerns that the large-scale removal of senior officers without clear justification could affect military readiness. In April 2026, Hegseth repealed the requirement for basic military trainees to receive the influenza vaccine. The requirement was restored in July 2026 after an outbreak at Joint Base San Antonio hospitalized four and killed one trainee. In July 2026, Hegseth announced that the military would begin testing service members' testosterone levels and providing hormone therapy. The policy was rescinded in September 2026.
Morgan State began playing football in 1898, 31 years after the school was founded. The Bears have won three MEAC Championships (1976, 1979 and 2014). Their last Division I-AA/FCS playoffs appearance was in 2014. Fifty-three former Morgan players have gone on to play professional football. Former Morgan Bears Len Ford, Leroy Kelly, Willie Lanier and Rosey Brown are members of the Pro Football Hall of Fame in Canton, Ohio.
Sources: en.wikipedia.org
=== Loss of solubility === When proteins are folded, they fold so as to keep their hydrophobic parts on the inside (away from water) and their hydrophilic parts on the outside (contacting the water). This makes them soluble enough not to precipitate. However, when denatured the surface of the protein is partly hydrophobic and partly hydrophilic (as it no longer has an "inside" in which to hide the hydrophobic parts), causing it to become insoluble in water. The hydrophobic parts of the denatured proteins stick together, forming a network (gel): this is called coagulation. The coagulation of denatured proteins is the reason eggs solidify when cooked. When acid is added to milk, the protein casein denatures and coagulates (with fat and water inclusions from the milk) into curds, the first step in making cheese; although milk can also be made to curdle (i.e. casein to coagulate) by other methods, for example the addition of enzymes like chymosin.
=== Sympatholytics === Sympatholytics are a group of anti-hypertensives which inhibit activity of the sympathetic nervous system. Beta blockers reduce anxiety by decreasing heart rate and preventing shaking. Beta blockers include propranolol, oxprenolol, and metoprolol. The alpha-1 antagonist prazosin could be effective for PTSD. The alpha-2 agonists clonidine and guanfacine have demonstrated both anxiolytic and anxiogenic effects.
=== New Zealand === On 12 March, the New Zealand Government released six days' worth of petroleum following a global directive by the International Energy Agency to release 400 million barrels of petrol in response to supply disruptions caused by the 2026 Iran war. On 24 March, the New Zealand Government announced that about 143,000 working families with children would receive a $50 tax credit to help with rising fuel costs from 7 April. Another 14,000 families were also expected to be eligible for a lower tax credit. On 27 March, the New Zealand Government released its four-level fuel alert level system in response to fuel shortages caused by the Iran conflict. That day the country was placed on the first phase, watchful, with the public advised to use fuel cautiously.
As the raids were being conducted in Brussels, the Italian State Police executed two European Arrest Warrants in Italy. Maria Colleoni, Panzeri's wife, was arrested at their family home in Calusco d'Adda, near Bergamo, Italy, and his daughter, Silvia Panzeri, was arrested later that evening in Milan. Both women were transferred to a prison in Bergamo for detention. As of 14 December 2022, they had been released under house arrest to a property in Lombardy. Shortly thereafter, Italian authorities raided the Italian home of Francesco Giorgi, where an additional €20,000 in cash was confiscated. The European Arrest Warrant confirmed reports that the charges against Panzeri were related to corruption and gifts he had received from nation-states. The publication of the warrant was the first time that Morocco was implicated in the scandal. The day after the raids, on 10 December, a further search was conducted at the home of Belgian MEP Marc Tarabella, Vice Chair of the European Parliament's Delegation for relations with the Arab Peninsula. Tarabella had not yet been arrested. On 12 December 2022, it was announced that the Greek Anti-Money Laundering Authority had frozen all of Kaili's assets, as well as those of her close family members. This included her bank accounts, safes, companies, and any other financial assets. The head of the Anti-Money Laundering Authority noted that a newly established estate agency in Kolonaki, an upmarket neighbourhood of Athens, was of particular interest to the investigation.
In 2012, the first detailed observational and histological studies of the mesocolon were undertaken and this revealed several new findings. The study included 109 patients undergoing open, elective, total abdominal colectomy. Anatomical observations were recorded during the surgery and on the post-operative specimens. These studies showed that the mesocolon is continuous from the ileocaecal to the rectosigmoid level. It was also shown that a mesenteric confluence occurs at the ileocaecal and rectosigmoid junctions, as well as at the hepatic and splenic flexures and that each confluence involves peritoneal and omental attachments. The proximal rectum was shown to originate at the confluence of the mesorectum and mesosigmoid. A plane occupied by perinephric fascia was shown to separate the entire apposed small intestinal mesentery and the mesocolon from the retroperitoneum. Deep in the pelvis, this fascia coalesces to give rise to presacral fascia.
Sources: en.wikipedia.org
=== Pseudomorphic replication === Pseudomorphic mineral replacement events occur whenever a mineral phase comes into contact with a fluid with which it is out of equilibrium. Re-equilibration will tend to take place to reduce the free energy and transform the initial phase into a more thermodynamically stable phase, involving dissolution and reprecipitation subprocesses. Inspired by such geological processes, MOF thin films can be grown through the combination of atomic layer deposition (ALD) of aluminum oxide onto a suitable substrate (e.g. FTO) and subsequent solvothermal microwave synthesis. The aluminum oxide layer serves both as an architecture-directing agent and as a metal source for the backbone of the MOF structure. The construction of the porous 3D metal-organic framework takes place during the microwave synthesis, when the atomic layer deposited substrate is exposed to a solution of the requisite linker in a DMF/H2O 3:1 mixture (v/v) at elevated temperature. Analogous, Kornienko and coworkers described in 2015 the synthesis of a cobalt-porphyrin MOF (Al2(OH)2tcpp-Co; H2tcpp-=4,4′,4″,4‴-(porphyrin-5,10,15,20-tetrayl)tetrabenzoate), the first MOF catalyst constructed for the electrocatalytic conversion of aqueous CO2 to CO.
=== Colon Treaty of Peace and Friendship === On August 26, 1876, the Grand Lodge of Colon in Santiago de Cuba declared itself entirely independent as a sovereign Masonic Body with its own full and unlimited powers over its own subordinate lodges. Under their auspices, the Grand Lodge of Colon possessed 36 lodges and 8,000 members. On November 24, 1876, the Grand Lodge of Colon and the Supreme Council of Colon signed the Tratado de Paz y Amistad (English: Treaty of Peace and Friendship). This treaty was based in the agreements of the Lausanne Congress. It degraded the superior prestige of the higher degrees, eliminated authoritarian positions at the Supreme Council, ejected the Spanish aristocracy from holding undue power, and erased the mystical positions. The Supreme Council of Colon recognized the Grand Lodge of Colon as "regular and correct," and also recognized their authority over the three degrees of the Blue Lodge. The Grand Lodge recognized the Supreme Council as the authority over the 4th to 33rd degrees.
==== Accreditation and regulation ==== Training Institutions: Hospitals and medical centers must be accredited by NPMCN and/or WACP/WACS to offer residency programs. Medical and Dental Council of Nigeria (MDCN): MDCN regulates medical and dental practice in Nigeria, ensuring that residency training aligns with national standards.
=== Lasso peptides === Lasso peptides are short peptides containing an N-terminal macrolactam macrocycle "ring" through which a linear C-terminal "tail" is threaded. Because of this threaded-loop topology, these peptides resemble lassos, giving rise to their name. They are a member of a larger class of amino-acid-based lasso structures. Additionally, lasso peptides are formally rotaxanes. The biosynthesis of lasso peptides is different from other RiPPs because the N-terminal leader peptide is cleaved first by a dedicated peptidase. After the cleavage, a lasso cyclase enzyme forms an isopeptide bond between the N-terminal amine of the first amino acid of the peptide and the carboxylate side chain of an aspartate or glutamate residue. This creates a constrained lasso peptide with three sections: the ring, the loop, and the tail. The ring is typically 7 to 9 amino acids long, while the C-terminal tail ranges from 7 to 15 amino acids in length. The first amino acid of lasso peptides is almost invariably glycine or cysteine, with mutations at this site not being tolerated by known enzymes. Thus, bioinformatics-based approaches to lasso peptide discovery have thus used this as a constraint. However, some lasso peptides were recently discovered that also contain serine, alanine, or tryptophan as their first residue. Other bioinformatics approaches use the peptidase involved in lasso peptide biosynthesis to discover new lasso peptide biosynthetic gene clusters.
Sources: en.wikipedia.org
A responder analysis counts participants who cross a threshold, such as five or ten percent weight loss. It complements average percent change by showing how widely results are distributed. The two measures can diverge when a subset of participants loses a large amount.
Mechanistic measures such as energy expenditure and liver fat change come from small substudies and should be read as preliminary. Long-term clinical outcomes are not yet available. Average weight loss figures are better supported than explanations for how the loss is achieved.
Endpoints reported at different weeks, in different baseline BMI ranges, or under different dose-escalation schedules are not directly comparable. Studies in type 2 diabetes often show smaller weight changes than studies in obesity without diabetes. Reporting the population alongside the number keeps comparisons honest.
Reversed-phase liquid chromatography with ultraviolet detection is the standard approach, reported as area percent of the main peak. Orthogonal methods such as mass spectrometry confirm that the main peak has the expected mass. Purity figures are only comparable when column, gradient, and wavelength are matched.